This presentation is a review of current knowledge on ALS biology, treatments and clinical trials. The genetic causes of ALS are described along with the known pathophysiology. The need for earlier diagnosis is explained along with new initiatives to improve the diagnostic journey. Current treatments and new treatments in development are described. Innovations in trial design and approaches that are in use in ALS and also expanding into the broader field of neurotherapeutics are discussed.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- Paid · fee on provider site
-
ReleasedMar 12, 2025
-
Last day to claim creditMar 12, 2028 1 year left
-
Physicians’ Education Resource Advances in(TM) Generalized Myasthenia Gravis: Continuing the Quest for Novel Therapies
-
Clinical Care Options, LLC (dba Decera Clinical Education) More Than a Memory: Advancing Early Diagnosis and Amyloid-Targeted Therapies for Alzheimer’s Disease
-
American Society of Neuroradiology Education Advances: Approach to Myelopathy & Lesions of the Spinal Cord
-
Washington State University Elson S. Floyd College of Medicine Course 2: ALS Treatments
-
Washington State University Elson S. Floyd College of Medicine Course 4: Respiratory Care of Individuals with ALS
-
Washington State University Elson S. Floyd College of Medicine Course 1: ALS Fundamentals: Pathophysiology, Prognosis, and Presentation
